Literature DB >> 21818149

Sex and type 2 diabetes: obesity-independent effects on left ventricular substrate metabolism and relaxation in humans.

Linda R Peterson1, Ibrahim M Saeed, Janet B McGill, Pilar Herrero, Kenneth B Schechtman, Ratnasiri Gunawardena, Carol L Recklein, Andrew R Coggan, Amanda J DeMoss, Carmen S Dence, Robert J Gropler.   

Abstract

Patients with type 2 diabetes (T2DM), particularly women, are at risk for heart failure. Myocardial substrate metabolism derangements contribute to cardiac dysfunction in diabetic animal models. The purpose of this study was to determine the effects of diabetes and sex on myocardial metabolism and diastolic function in humans, separate from those of obesity. Thirty-six diabetic subjects (22 women) and 36 nondiabetic, BMI-matched subjects (21 women) underwent positron emission tomography (myocardial metabolism) and echocardiography (structure, function). Myocardial blood flow and oxygen consumption (MVO(2)) were higher in women than men (P = 0.003 and <0.0001, respectively). Plasma fatty acid (FA) levels were higher in diabetics (vs. obese, P < 0.003) and sex and diabetes status interacted in its prediction (P = 0.03). Myocardial FA utilization, oxidation, and esterification were higher and percent FA oxidation lower in diabetics (vs. obese, P = 0.0004, P = 0.007, P = 0.002, P = 0.02). FA utilization and esterification were higher and percent FA oxidation lower in women (vs. men, P = 0.03, P = 0.01, P = 0.03). Diabetes and sex did not affect myocardial glucose utilization, but myocardial glucose uptake/plasma insulin was lower in the diabetics (P = 0.04). Left ventricular relaxation was lower in diabetics (P < 0.0001) and in men (P = 0.001), and diabetes and sex interacted in its prediction (P = 0.03). Sex, T2DM, or their interaction affect myocardial blood flow, MVO(2), FA metabolism, and relaxation separate from obesity's effects. Sexually dimorphic myocardial metabolic and relaxation responses to diabetes may play a role in the known cardiovascular differences between men and women with diabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21818149      PMCID: PMC3314727          DOI: 10.1038/oby.2011.208

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  40 in total

1.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

2.  Quantitation of myocardial fatty acid metabolism using PET.

Authors:  S R Bergmann; C J Weinheimer; J Markham; P Herrero
Journal:  J Nucl Med       Date:  1996-10       Impact factor: 10.057

Review 3.  Influence of free fatty acids on myocardial oxygen consumption and ischemic injury.

Authors:  H Vik-Mo; O D Mjøs
Journal:  Am J Cardiol       Date:  1981-08       Impact factor: 2.778

4.  Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.

Authors:  T Utriainen; T Takala; M Luotolahti; T Rönnemaa; H Laine; U Ruotsalainen; M Haaparanta; P Nuutila; H Yki-Järvinen
Journal:  Diabetologia       Date:  1998-05       Impact factor: 10.122

5.  Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus.

Authors:  John K Boyer; Srihari Thanigaraj; Kenneth B Schechtman; Julio E Pérez
Journal:  Am J Cardiol       Date:  2004-04-01       Impact factor: 2.778

6.  Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes.

Authors:  Linda R Peterson; Pilar Herrero; Janet McGill; Kenneth B Schechtman; Zulfia Kisrieva-Ware; Donna Lesniak; Robert J Gropler
Journal:  Diabetes       Date:  2007-10-03       Impact factor: 9.461

7.  Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging.

Authors:  Linda R Peterson; Alan D Waggoner; Kenneth B Schechtman; Timothy Meyer; Robert J Gropler; Benico Barzilai; Víctor G Dávila-Román
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

8.  Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.

Authors:  Rutger W van der Meer; Luuk J Rijzewijk; Hugo W A M de Jong; Hildo J Lamb; Mark Lubberink; Johannes A Romijn; Jeroen J Bax; Albert de Roos; Otto Kamp; Walter J Paulus; Robert J Heine; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant
Journal:  Circulation       Date:  2009-04-06       Impact factor: 29.690

9.  Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction.

Authors:  Stuart A Cook; Anabel Varela-Carver; Marco Mongillo; Christina Kleinert; Muhammad T Khan; Lucia Leccisotti; Nicola Strickland; Takashi Matsui; Saumya Das; Anthony Rosenzweig; Prakash Punjabi; Paolo G Camici
Journal:  Eur Heart J       Date:  2009-10-01       Impact factor: 29.983

10.  Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.

Authors:  T Ohtake; I Yokoyama; T Watanabe; T Momose; T Serezawa; J Nishikawa; Y Sasaki
Journal:  J Nucl Med       Date:  1995-03       Impact factor: 10.057

View more
  40 in total

1.  Myocardial Energetics in Heart Failure With Preserved Ejection Fraction.

Authors:  Omar F AbouEzzeddine; Bradley J Kemp; Barry A Borlaug; Brian P Mullan; Atta Behfar; Sorin V Pislaru; Marat Fudim; Margaret M Redfield; Panithaya Chareonthaitawee
Journal:  Circ Heart Fail       Date:  2019-10-15       Impact factor: 8.790

Review 2.  Identifying the Critical Gaps in Research on Sex Differences in Metabolism Across the Life Span.

Authors:  Jane E B Reusch; T Rajendra Kumar; Judith G Regensteiner; Philip S Zeitler
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

Review 3.  Recent advances in metabolic imaging.

Authors:  Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

Review 4.  Cardiac nuclear receptors: architects of mitochondrial structure and function.

Authors:  Rick B Vega; Daniel P Kelly
Journal:  J Clin Invest       Date:  2017-02-13       Impact factor: 14.808

Review 5.  Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association.

Authors:  Heinrich Taegtmeyer; Martin E Young; Gary D Lopaschuk; E Dale Abel; Henri Brunengraber; Victor Darley-Usmar; Christine Des Rosiers; Robert Gerszten; Jan F Glatz; Julian L Griffin; Robert J Gropler; Hermann-Georg Holzhuetter; Jorge R Kizer; E Douglas Lewandowski; Craig R Malloy; Stefan Neubauer; Linda R Peterson; Michael A Portman; Fabio A Recchia; Jennifer E Van Eyk; Thomas J Wang
Journal:  Circ Res       Date:  2016-03-24       Impact factor: 17.367

Review 6.  Imaging of myocardial fatty acid oxidation.

Authors:  Kieren J Mather; Timothy R DeGrado
Journal:  Biochim Biophys Acta       Date:  2016-02-27

7.  Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety.

Authors:  D Nathanson; B Ullman; U Löfström; A Hedman; M Frick; A Sjöholm; T Nyström
Journal:  Diabetologia       Date:  2012-01-13       Impact factor: 10.122

Review 8.  The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise.

Authors:  Joel D Schilling
Journal:  Antioxid Redox Signal       Date:  2015-04-15       Impact factor: 8.401

9.  A Diet Rich in Medium-Chain Fatty Acids Improves Systolic Function and Alters the Lipidomic Profile in Patients With Type 2 Diabetes: A Pilot Study.

Authors:  Sophia Airhart; W Todd Cade; Hui Jiang; Andrew R Coggan; Susan B Racette; Kevin Korenblat; Catherine Anderson Spearie; Suzanne Waller; Robert O'Connor; Adil Bashir; Daniel S Ory; Jean E Schaffer; Eric Novak; Marsha Farmer; Alan D Waggoner; Víctor G Dávila-Román; Cylen Javidan-Nejad; Linda R Peterson
Journal:  J Clin Endocrinol Metab       Date:  2015-12-10       Impact factor: 5.958

10.  Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.

Authors:  K J Mather; G D Hutchins; K Perry; W Territo; R Chisholm; A Acton; B Glick-Wilson; R V Considine; S Moberly; T R DeGrado
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-01-05       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.